The acute effect of sertindole on brain 5-HT2, D2 and ?1 receptors (ex vivo radioreceptor binding studies)
- 1 February 1992
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 89 (1-2), 61-69
- https://doi.org/10.1007/bf01245352
Abstract
The ability of sertindole to influence the ex vivo binding of3H-ketanserin,3H-prazosin and3H-spiperone to 5-HT2 receptors, α1-adrenoceptors and DA D2 receptors, respectively, in rat brain has been studied after acute treatment. Sertindole is a potent, long acting compound which readily passes the blood-brain barrier. It dose-dependently binds to all three receptors types. In line with in vivo behavioural experiments sertindole has the most pronounced effect on 5-HT2 receptors, lower effect on α1-adrenoceptors and the lowest effect on striatal D2 receptors.Keywords
This publication has 12 references indexed in Scilit:
- Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: Acute and repeated treatmentSynapse, 1992
- Neurochemical and in vivo pharmacological profile of sertindole, a limbic‐selective neuroleptic compoundDrug Development Research, 1991
- Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the ratEuropean Journal of Pharmacology, 1990
- Age Related Decrease in the Density of Dopamine D1 and D2 Receptors in Corpus Striatum of RatsBasic & Clinical Pharmacology & Toxicology, 1987
- Effect of Prolonged Treatment with Neuroleptics on Dopamine D‐1 and D‐2 Receptor Density in Corpus Striatum of MiceActa Pharmacologica et Toxicologica, 1986
- Neurochemical Profile of Lu 19‐005, a Potent Inhibitor of Uptake of Dopamine, Noradrenaline, and SerotoninJournal of Neurochemistry, 1985
- Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine NeuronsScience, 1983
- How to analyze binding, enzyme and uptake data: The simplest case, a single phaseLife Sciences, 1982
- A lipophilic, selective α1 -adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino) imidazolidine (St 587)Life Sciences, 1981
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978